Cerebrolisin in the system of neurogeriatric rehabilitation of the patients with ishemic stroke
pdf

Keywords

stroke, neuroprotection, old age, cerebral hemodynamics, bioelectrical activity of the brain.

How to Cite

Kuznetsov, V. (2020). Cerebrolisin in the system of neurogeriatric rehabilitation of the patients with ishemic stroke. The Journal of Neuroscience, 8(1-2), 35-42. Retrieved from https://neuroscience.com.ua/index.php/journal/article/view/230

Abstract

The article presents an analysis of the complex effect of Cerebrolysin (10 ml i.v № 10) on cerebral hemodynamics and bioelectrical activity of the brain in elderly patients with atherothrombotic ischemic stroke (25 patients). In patients with stroke, under the influence of Cerebrolysin improves cerebral blood flow (increased LBFV, reduced peripheral resistance). Cerebrolysin improves brain metabolism, as evidenced by the harmonization of bioelectrical activity of the brain, more pronounced in patients with localization of the ischemic focus in the left hemisphere. The interhemispheric effect of Cerebrolysin is due to the functional and biochemical asymmetry of the brain. The multimodal effect of Cerebrolysin determines the feasibility of using the drug to correct post-stroke changes in the functional state of the brain in elderly patients during rehabilitation.

pdf

References

1. Barolin G.S., Koppi S., Kapeller E. Old and new aspects of stroke treatment with emphasis on meta-bolically active medication and rehabilitative outcome // Euro
Rehab. — 1996. — 3. — Р. 135-143.
2. Haffner Z. Efficacy of Cerebrolysin in patients with acute ischaemic stroke // Final. Study Report. — 2000. — P. 1-34.
3. Hassanein S.M., Deifalla S.M., El-Houssinie M., Mokbel S.A. Safety and Efficacy of Cerebrolysin in Infants with Communication Defects due to Severe Perinatal Brain Insult: A Randomized Controlled Clinical Trial // J. Clin. Neurol. — 2016. — 12 (1). — P. 79-84.
4. Herrschaft H. Wirksamkeit von Cerebrolysin bei akutem ischämischen Hirninfarct // Integrierter klinischer Studienbericht. — 1998. — P. 1-74.
5. Jayasundar R. human brain: biochemical lateralization in normal subjects // Neurol. India. — 2002. — Vol. 5, № 3.
6. Kuznetsov V., Bulchak V. Hemispheric Reculiarities of cerebrolysin effects on the Brain Functional State in Patients with Athrerotrombotic Ischemic Stroke // SM
Gerontology and Geriatric Research. — 2017. — 1 (1).
7. Muresanu D.F. Neurotrophic factors. — Bucuresti: Libripress, 2003.
8. Rainer M. Improved global function and activites of daily living in patients with AD: placebo-controlled clinical study with the neurothropic agent Cerebrolysin //
J. Neural. Transm. Supply. — 2002. — (62). — P. 277-285.
9. Torshin J. Bioinformatics in the post-genomic era: physiology and medicine / Nova Biomedical Books. — NY.USA, 2007. — P. 1-20.
10. Veinbergs J., Mante M., et al. Neurotrophic effects of Cerebrolysin in animal models of excitotoxicity // J. Neural. Transm. — 2000. — 59. — P. 273-280.
11. Wong G.K., et al. Beneficial effect of cerebrolysin on moderate and severe head injury patients: result of a cohort study // Acta Neurochir. — 2005. — 95. —
P. 59-60.
12. Wronski R., et al. Inhibitory effect of a orain derived peptide preparation on the Ca2+ dependent protease calpain // J. Neural. Transm. — 2006. — 107 (2). —
P. 145-157.
13. Carey Z.M. Stroke rehabilitation. — Oxford University Press, 2012. — P. 257.
14. Брайник М. Церебролизин как мультимодальный препарат для лечения пациентов с инсультом. Новые перспективы // МНЖ. — 2019. — № 3. — С. 83-86.
15. Гехт А.Б., Гусев Е.И. Лечение больных инсультом в восстановительный период // Doctor. — 2003. — № 3. — C. 33-35.